People

Petra Kaufmann

Chief medical officer of Ovid Therapeutics. Previously served as chief medical officer of Vigil Neuroscience and Affinia Therapeutics, and held clinical development leadership at Novartis Gene Therapies and AveXis. Earlier led the NIH Office of Rare Diseases Research. A neurologist with an MD from Bonn and an MS in biostatistics from Columbia.